Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SB204 in acne vulgaris
NCT02667444Phase 3Completed
- Sponsor
- Novan
- Start
- Feb 2016
- Primary completion
- Dec 2016
- Modality
- Polymer-based Nanoparticles, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of berdazimer in acne vulgaris, sponsored by Novan. Started Feb 2016; status: completed.
02
Drugs
berdazimer
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT02667444.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02667444.